相关实验视频
Updated: Jun 9, 2026
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.4K
通过L-氨酸修饰的高分支聚-L-氨酸对不同SARS-CoV-2变种的体外抗病毒活性
Federico Fiori1, Franca Lucia Cossu1, Federica Salis1
1Laboratory of Materials Science and Nanotechnology (LMNT), CR-INSTM, Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43/B, 07100 Sassari, Italy.
Nanomaterials (Basel, Switzerland)
|December 22, 2023
概括
修改后的纳米聚合物显示出对抗SARS-CoV-2变种的前景. L-氨酸增强的高分支聚-L-氨酸纳米聚合物有效抑制了Omicron变体的复制,提供了一个潜在的宽谱抗病毒策略.
科学领域:
- 生物材料科学 生物材料科学
- 病毒学 病毒学
- 纳米技术纳米技术
背景情况:
- 新兴的SARS-CoV-2变种,如Omicron,表现出高传染性和免疫逃避.
- 开发广泛的抗病毒药物对于对抗当前和未来的病毒大流行至关重要.
- 超分支的聚-L-氨酸纳米聚合物证明了对原始SARS-CoV-2菌株的有效性.
研究的目的:
- 为了合成和评估L-氨酸修饰的高分支聚-L-氨酸纳米聚合物.
- 评估这些纳米聚合物对SARS-CoV-2原始,Delta和Omicron菌株的抗病毒活性.
- 为了确定改性纳米聚合物的安全性和治疗指数.
主要方法:
- 超分支聚-L-氨酸通过酸催化的热反应与L-氨酸进行了修饰.
- 在体外对SARS-CoV-2菌株进行了抗病毒活性评估.
- 用体外预防模型评估了细胞毒性和治疗指数.
主要成果:
- 成功合成了L-氨酸修饰的纳米聚合物 (Lys-Arg).
- 修改后的纳米聚合物显示治疗指数与原始SARS-CoV-2菌株相比增加了12倍.
- 在细胞培养物中观察到有效抑制Omicron变异复制.
结论:
- L-氨酸修饰显著增强了聚-L-氨酸纳米聚合物的抗病毒潜力.
- 这些增强的纳米聚合物表现出广泛的活性,包括对抗Omicron变种.
- 开发的纳米聚合物代表了针对SARS-CoV-2的新型抗病毒疗法的有希望的候选者.
相关概念视频
01:29Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...